HMGB2 and central nervous system cancer: While HMGB2 expression (continuous values) was not associated with any of the clinical features, it was significantly associated with histological criteria that define grade 4 gliomas, such as mitotic count (representing proliferative activity—p = 0.0092) and glomeruloid vessels (p = 0.017).